Top of page.
Barrière logo

Research & Trials Disclosure

The information presented in this section is provided for educational and informational purposes only and is intended to share published scientific literature, ingredient-related research, consumer perception findings, and internal product experience data related to Barrière products and transdermal delivery technologies.

Certain materials referenced within this section summarize or link to third-party publications, including peer-reviewed articles, abstracts, and research indexed through external sources such as. External studies are independent of Barrière unless otherwise expressly stated. References to published research are provided to support broader scientific discussion regarding ingredients, mechanisms, delivery methods, or wellness-related topics and do not constitute proof that the same results will occur from use of any Barrière product.

Certain content within this section may also summarize findings from internal consumer perception studies, user experience evaluations, pilot programs, observational feedback, or other non-clinical assessments conducted by or on behalf of Barrière. Unless specifically stated otherwise, these evaluations:

  • were not designed or conducted as FDA-approved clinical trials;
  • may not have been placebo-controlled, blinded, randomized, or independently verified;
  • may involve limited sample sizes;
  • may rely in part on subjective participant feedback and self-reported experiences; and
  • should not be interpreted as conclusive scientific evidence of efficacy or health outcomes.

Any participant-reported experiences, testimonials, diary entries, or summarized findings reflect individual experiences only. Individual results may vary significantly based on factors including age, health status, lifestyle, consistency of use, and adherence to product directions.

Example study context shown within this section may include language such as:

“Based on an internal consumer perception study of 30 participants ages 28–72 following 6 weeks of use of two (2) Barrière NAD+ transdermal patches applied every other day.”

The statements and products referenced within this website have not been evaluated by the U.S. Food and Drug Administration. Barrière products are not intended to diagnose, treat, cure, or prevent any disease.

Nothing contained within this section is intended to constitute medical advice, healthcare guidance, or a substitute for consultation with a qualified healthcare professional. Consumers should consult their physician or other licensed healthcare provider before beginning any wellness, supplementation, or transdermal product regimen, particularly if pregnant, nursing, taking medication, or managing a medical condition.